Background Patients diagnosed with high risk localized prostate cancer have variable
outcomes following surgery. Trials of intense neoadjuvant androgen deprivation therapy (NADT) …

Purpose: Therapies targeting the androgen receptor (AR) have improved the outcome for
patients with castration-sensitive prostate cancer (CSPC). Expression of the constitutively …

Localized prostate cancers are genetically variable and frequently multifocal, comprising
spatially distinct regions with multiple independently-evolving clones. To date there is no …

Purpose: For high-risk prostate cancer, standard treatment options include radical
prostatectomy (RP) or radiotherapy plus androgen deprivation therapy (ADT). Despite definitive …

Four benzoxazole-substituted GFP chromophores that differ by the length of their alkyl chain
(from C1 to C12) were synthesized. In solution, the four compounds showed identical …

Solvent selection guides are crucial in chemical process design and development. Lignin
from lignocellulosic biomass is a potentially attractive feedstock for sustainable chemical …

… Richard Clark, who is a direct descendent of John Bright and the custodian of the Bright …
and Tim Crumplin, who painstakingly reproduced many of Bright’s letters and papers, Duncan …

… This was Bright's judg ment on himself, and it is profoundly … When one reads the description
of Bright's daily life, as drawn … cul ture?had no attraction for Bright. He knew his Bible and he …

Patients diagnosed with localized high-risk prostate cancer have uncertain outcomes, and
the introduction of neoadjuvant intensive hormonal therapies seeks to treat occult …

Purpose: Neoadjuvant intense androgen deprivation therapy (iADT) can exert a wide range
of histological responses, which in turn are reflected in the final prostatectomy specimen. …